Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2008-05-27
2008-05-27
Hui, San-ming (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S181000
Reexamination Certificate
active
10762652
ABSTRACT:
Stabilized 17-substituted hydrocortisone containing compositions and methods of manufacture. Isomerization of the hydrocortisone component of topical steroid compositions is markedly reduced by introducing an omega-6. acid in the form of linoleic acid into the skin preparation. Preferably, the linoleic acid is added as a component of refined safflower oil. The omega-6 acid has been found to be an effective way of preventing the isomerization of hydrocortisone 17-butyrate into the undesirable isomer HC21-B.
REFERENCES:
patent: 4344940 (1982-08-01), Chow et al.
patent: 5496565 (1996-03-01), Heinze et al.
patent: 5650156 (1997-07-01), Grinstaff et al.
patent: 5665383 (1997-09-01), Grinstaff et al.
patent: 5968519 (1999-10-01), Youssefyeh et al.
patent: 6090800 (2000-07-01), Unger et al.
patent: 6245340 (2001-06-01), Youssefyeh
Remington's Pharmaceutical Sciences, 18th ed., 1990, pp. 956-971.
Hui San-ming
Pharmaceutical Patent Attorneys, LLC
Triax Pharmaceuticals, LLC
LandOfFree
Stabilized steroid composition and method for its preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilized steroid composition and method for its preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized steroid composition and method for its preparation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3920073